Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9219548 | 0.84 | CYP1A2 (0.52) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL4895772 | 0.84 | CA12 (0.56) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL65725 | 0.84 | CA12 (0.56) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL9215334 | 0.83 | CYP1A2 (0.52) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL9195440 | 0.82 | CA12 (0.54) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL2114791 | 0.82 | CA12 (0.54) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL238471 | 0.82 | CA12 (0.54) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL8897310 | 0.81 | CYP1A2 (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL8952122 | 0.81 | CA12 (0.62) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL7850805 | 0.81 | CYP1A2 (0.47) | CYP1A2CYP3A4CYP2C9CYP2C19GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991013065-A1 | 6-ARYL-2-SUBSTITUTED BENZOIC ACID HERBICIDES | FMC CORPORATION (US) | 1991-09-05 | — | — | WO | disclosed |